Table 1.
A. Microbial species | |||||
---|---|---|---|---|---|
Organism | Effects on skin | Mechanism | References | ||
Faecalibacterium prausnitzii, Akkermansia muciniphila and Ruminoccocus | Protection against psoriasis | Prevention of colonization of pathogenic flora on skin by competitive inhibition and the SCFAs production | 158,159,169,213 | ||
Helicobacter pylori | Rosacea-related signs and symptoms | Production of cytotoxin and by proliferating the production of reactive oxygen species-nitric oxide [NO], which causes gut mucosal inflammation and changes physiological processes in the skin including vasodilation, inflammation and immunomodulation. | 194 | ||
Faecalibacterium prausnitzii | Chronic atopic dermatitis progression resulting in gut epithelial barrier impairment | Dysregulation of gut epithelial inflammation | 180 | ||
Lactobacillus casei | Decrease skin inflammation | Alteration of the number of cytotoxic CD8 + T cells | 171 | ||
Lactobacillus paracasei | Reduce the size of acne lesions as well as inflammation | Inhibition of mast cell degranulation, TNF-α release, edema and vasodilation, and thereby speeding up the restoration of barrier function |
145,171 136 |
||
Bifidobacterium animalis subsp. lactis [LKM512] | Reduce the scratching behavior in atopic dermatitis | Increase of levels of the kynurenic acid metabolite | 223 | ||
Bacteroides thetaiotaomicron | Alleviate the allergic symptoms of atopic dermatitis as well as Crohn’s disease like other chronic inflammatory diseases | Anti-inflammatory action | 228 | ||
Larger number of Clostridium difficile and Escherichia coli |
Onset of atopic dermatitis symptoms in childhood | Immune dysregulation as a result of decreased Treg cell inducing beneficial bacteria | 16,224 | ||
Decrease in Firmicutes and increase in Bacteroides |
Development of acne vulgaris |
Dysbiosis by altering the serological cytokine levels promoting inflammation |
15,188 |
||
B. Metabolites | |||||
Metabolites |
Effects on skin |
Mechanism |
References |
||
SCFAs | Increase the epithelial barrier function and skin-inflammation | Development of Tregs within the colon, DCs precursors, and IL-10 production |
120,229 13,106 |
||
GABA | Itch restriction | Inhibition of neurons which are responsible for itch-signaling in the spinal cord | 230,223 | ||
Tryptophan | Regulate skin inflammation | Activation of AhR and inhibition of TSLP production in keratinocytes | 231 | ||
Dopamine | Inhibition of hair growth | Through the stimulation of catagen induction | 98 | ||
Serotonin | Involved in skin pigmentation | Modulation of melatonin | 16,223 | ||
Acetylcholine | Barrier function | Not reported | 16 | ||
Phenol & p-cresol | Impaired epidermal barrier function | Skin hydration reduction and disruption of keratinization | 171,232 | ||
Propionic acid | Promote skin homeostasis by reducing inflammation | Antimicrobial effects | 2 | ||
Sodium butyrate | Treat psoriasis and other hyperproliferative skin diseases | Modulation of several key cellular processes including differentiation, proliferation, and apoptosis. | 137 | ||
Galactoligosaccharides and fructooligosaccharides |
Reduction of infant eczema and allergy | Through the stimulation of Tregs | 13,107 | ||
Polysaccharide A and retinoic acid | Suppress inflammation | Induction of accumulation of Tregs | 153 | ||
Saturated fats and higher amount of glycemic load |
Development of acne | Impairment in nutrient signaling. SREBP-1 overexpression and increased sebum synthesis of fatty acids (e.g., free oleic acid) and triglycerides which promotes flourishing. P. acnes growth | 107 | ||
High-peptides and unsaturated omega-3 fatty acids | Act against hypersensitivity (allergies) and asthma | Through the development of Tregs | 13 | ||
High-fat and alcohol | Promote skin inflammation and oxidative stress. Impairment of colonic epithelial integrity and barrier function. |
Increase of pro-inflammatory cytokines secretion | 122,123 |